Global Vital Sign: Innovation in Cell Culture to Combat Cancer and Develop Next-Generation Drugs
Boehringer Ingelheim and Biberach: A Hub for Biotechnology
Biberach, Germany, stands as a prominent center for the development and production of biopharmaceutical active ingredients based on cell culture technology. The city is home to Boehringer Ingelheim, a leading pharmaceutical company renowned for its groundbreaking research and commitment to innovation in the field of cell culture.
Boehringer Ingelheim's Presence in Biberach
Boehringer Ingelheim's sprawling facility in Biberach employs over 7500 individuals, spanning various disciplines, including research, development, administration, and biopharmaceutical contract manufacturing. The company's extensive operations encompass over 415,000 square meters.
Within this state-of-the-art facility, Boehringer Ingelheim focuses on the downstream development of recombinant protein solutions. This process involves the purification and concentration of these proteins, which play a crucial role in the production of biopharmaceutical drugs used to treat a wide range of diseases, including cancer.
Boehringer Ingelheim's expertise in cell culture and biopharmaceutical manufacturing has positioned Biberach as a significant hub for biotechnology and innovation. The company's ongoing investments in research and development continue to drive advancements in the field, fostering hope for the development of new and more effective treatments for patients around the globe.
Comments